| Not Yet Recruiting | Oteseconazole in the Treatment of Adults With Vulvovaginal Candidiasis（VVC） NCT07044947 | Beijing Tsinghua Chang Gung Hospital | — |
| Recruiting | Effect of a Multi-strain Probiotic on Recurrent Vulvovaginal Candidiasis NCT06480604 | The Archer-Daniels-Midland Company | N/A |
| Not Yet Recruiting | Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection NCT06450990 | NEXBIOME THERAPEUTICS | Phase 1 / Phase 2 |
| Recruiting | DeVEnIR: Defining Vulvovaginal Candidiasis - Elements of Infection and Remedy NCT06397248 | University Hospital, Antwerp | — |
| Recruiting | Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome NCT05753813 | Queen's Medical Center | EARLY_Phase 1 |
| Completed | Pharmacokinetic Study in Healthy Lactating Women Exposed to Ibrexafungerp NCT06954493 | Scynexis, Inc. | Phase 1 |
| Unknown | Zinc-containing Vaginal Gel and Oral Fluconazole for Vulvovaginal Candidiasis. NCT05895162 | FEMPHARMA Kft. | N/A |
| Completed | Clinical Performance of the Gedea Pessary in Adult Women With Vulvovaginal Candidiasis NCT05507333 | Gedea Biotech AB | N/A |
| Completed | Multi-Gyn FloraFem Study for Treatment of Vulvo Vaginal Candidiasis Symptoms NCT05552378 | Karo Pharma AB | N/A |
| Recruiting | Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes NCT05908682 | Scynexis, Inc. | — |
| Withdrawn | Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis. NCT05031481 | EMS | Phase 2 |
| Completed | VVC Sampling Study for Analysis Validation NCT05327192 | Gedea Biotech AB | — |
| Completed | Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis NCT05399641 | Scynexis, Inc. | Phase 3 |
| Recruiting | Comparative Performance of a Vaginal Yeast Test NCT05079711 | Uniformed Services University of the Health Sciences | — |
| Unknown | Evaluation of VagiVitalAC for Treatment of Candida Vulvovaginitis NCT05012852 | PepTonic Medical AB | N/A |
| Unknown | Comparison of Boric Acid vs. Terconazole in Treatment of RVVC NCT04208555 | Hatem AbuHashim | N/A |
| Completed | Clinical Performance of a Vaginal Pessary (pHyph) in Vulvovaginal Candidiasis NCT03761628 | Gedea Biotech AB | N/A |
| Withdrawn | Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidia NCT02907307 | Medinova AG | Phase 3 |
| Unknown | Patients With Vulvovaginal Candidiasis NCT03024502 | University of Sao Paulo | Phase 1 / Phase 2 |
| Completed | TOL-463 Phase 2 Study for Vaginitis NCT02866227 | Toltec Pharmaceuticals, LLC | Phase 2 |
| Completed | Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidi NCT02679456 | Scynexis, Inc. | Phase 2 |
| Completed | Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidia NCT02242695 | Medinova AG | Phase 4 |
| Completed | Comparing NAAT Testing to Standard Methods for the Diagnosis of Vaginitis NCT02203942 | University of Pittsburgh | — |
| Completed | Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis NCT02180100 | Peking University Shenzhen Hospital | Phase 4 |
| Completed | Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candi NCT01926028 | NovaDigm Therapeutics, Inc. | Phase 1 / Phase 2 |
| Completed | The Study Of Fluconazole For Vulvovaginal Candidiasis NCT01806623 | Pfizer | Phase 3 |
| Completed | Study of the Microbiota, Metabolome, and Environmental Toxins in Relation to Reproductive Health in Rwandan Wo NCT02150655 | Western University, Canada | EARLY_Phase 1 |
| Completed | MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidia NCT01497223 | MethylGene Inc. | Phase 2 |
| Completed | Arasertaconazole Nitrate Pessaries - Dose Finding Study for the Vulvovaginal Candidiasis (VVC) Treatment NCT01144286 | Ferrer Internacional S.A. | Phase 2 |
| Completed | Comparative Efficacy of Ovule vs Tablet NCT00755053 | Bayer | Phase 3 |
| Completed | A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% Formul NCT01039584 | Padagis LLC | N/A |
| Completed | Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina NCT00194324 | University of Pennsylvania | Phase 4 |
| Completed | Diabetes Mellitus and Vulvovaginal Candidiasis NCT00353561 | Indian Council of Medical Research | Phase 3 |
| Completed | Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazo NCT00803738 | Padagis LLC | N/A |
| Completed | Monthly Itraconazole Versus Classic Homeopathy for Treatment of Recurrent Vulvovaginal Candidiasis (RVVC) NCT00895453 | Medical University of Vienna | N/A |